Amarin Corp. (AMRN) Tops Q3 EPS by 4c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Amarin Corp. (AMRN) Tops Q3 EPS by 4c, Revenues Beat

Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations

November 5, 2019 5:00 AM EST

Record Revenue Levels and Preparations On-Track for Further Expansion

Management to Host Conference Call at 7:30 a.m. ET Today

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced financial results for the three and nine months ended September 30, 2019 and provided an update on company operations. Key Amarin achievements since its last quarterly report include:

Record total revenue: Reported total revenue of $112.4 million and $286.5... More